Related Experiment Video
Updated: Sep 2, 2025
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Pressure-Controlled Intermittent Coronary Sinus Occlusion: A Novel Approach to Improve Microvascular Flow and Reduce
C Michael Gibson1, Issameddine Ajmi2, Cajetan L von Koenig3
1Beth Israel Lahey, USA; Baim Institute for Clinical Research (FKA Harvard Clinical Research Institute), USA; Harvard Medical School, USA.
Insights
Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) may improve outcomes for ST-segment elevation myocardial infarction (STEMI) patients. This novel technology aims to reduce infarct size and microvascular dysfunction following primary percutaneous coronary intervention.
Area of Science:
- Cardiology
- Interventional Cardiology
- Biomedical Engineering
Background:
- Primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) often results in suboptimal myocardial salvage.
- Microvascular dysfunction post-PCI is a significant contributor to adverse outcomes in STEMI patients, including heart failure and mortality.
Purpose of the Study:
- To evaluate the safety and effectiveness of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) in mitigating microvascular dysfunction during primary PCI for STEMI.
- To assess the impact of PiCSO on infarct size and microvascular perfusion in STEMI patients.
Main Methods:
- Non-randomized studies have explored PiCSO use during primary PCI.
- Ongoing randomized trials are investigating PiCSO in high-risk anterior STEMI patients undergoing primary PCI.
Main Results:
- Preliminary non-randomized data suggest PiCSO is safe and improves microvascular perfusion.
- Initial findings indicate that PiCSO may reduce infarct size in STEMI patients.
Conclusions:
- PiCSO is a promising technology for improving outcomes in STEMI patients undergoing primary PCI.
- Further randomized trials are necessary to confirm the benefits of PiCSO in reducing infarct size and preventing heart failure in STEMI.
Abstract:
Despite successful primary percutaneous coronary intervention (PCI) for treatment of ST-segment elevation myocardial infarction (STEMI), myocardial salvage is frequently suboptimal resulting in large infarctions with increased rates of heart failure and death. Microvascular dysfunction after the procedure is frequently present and contributes directly to poor outcomes in STEMI. Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) is a novel technology designed to mitigate microvascular dysfunction in STEMI. Non-randomized studies have suggested that PiCSO use during primary PCI in STEMI is safe, improves microvascular perfusion and reduces infarct size. Randomized trials are ongoing to investigate the safety and effectiveness of PiCSO in high-risk patients with anterior STEMI undergoing primary PCI.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction
01:27Coronary Artery Disease V: Interprofessional Care